EL PASO, TX--(Marketwired - Jun 29, 2017) - Premier Biomedical, Inc. (
CBD Hemp Oil Skin Patch is the first product that will be manufactured under this relationship, with additional products envisioned to be included in the near future.
SinglePoint CEO, Greg Lambrecht, stated, "We have been working very hard on making acquisitions and inside sales to boost revenues. This new business will contribute significantly to our revenue goals."
William A. Hartman, President/CEO and co-founder of Premier Biomedical stated, "We are excited that we found a volume supplier for our products. This significantly increases the company's initiatives and enables us to grow revenues through expansion of sales volumes in both domestic and foreign markets. We look forward to working with SinglePoint to continue building current and future planned new products."
About SinglePoint, Inc.
SinglePoint, Inc. (
About Premier Biomedical, Inc.
Premier Biomedical, Inc. (
Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Premier Biomedical, Inc. cautions that statements and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.